
Pedea - European Medicines Agency (EMA)
Pedea is a solution for injection that contains the active substance ibuprofen. What is Pedea used for? Pedea is used to treat ‘patent ductus arteriosus’ in newborn premature babies who were born six or more weeks too early (less than 34 weeks gestational age).
pdea.gov.ph
The Philippine Drug Enforcement Agency (PDEA) is responsible for enforcing the country's drug laws and regulations.
Before administration of Pedea an adequate echocardiographic examination should be performed in order to detect a haemodynamically significant patent ductus arteriosus and to exclude pulmonary hypertension and ductal-dependent congenital heart disease.
Pedea 5 mg/ml solution for injection - Summary of Product ...
Jan 28, 2025 · Pedea should be administered as a short infusion over 15 minutes, preferably undiluted. If necessary, the injection volume may be adjusted with either sodium chloride 9 mg/ml (0.9%) solution for injection or glucose 50 mg/ml (5%) solution for injection.
Pedea is a solution for injection that contains the active substance ibuprofen. What is Pedea used for? Pedea is used to treat ‘patent ductus arteriosus’ in newborn premature babies who were born six or more weeks too early (less than 34 weeks gestational age).
Pedea - European Drugs Reference Encyclopedia
What is Pedea? Pedea is a solution for injection that contains the active substance ibuprofen. What is Pedea used for? Pedea is used to treat ‘patent ductus arteriosus’ in newborn premature babies who were born six or more weeks too early (less than 34 weeks gestational age).
Pedea 5mg/ml solution for injection - Lekovi
Pedea, when given to your baby, can help to close the ductus arteriosus. The active substance in Pedea is ibuprofen. Pedea closes the ductus arteriosus by inhibiting the production of prostaglandin, a naturally occurring chemical in the body which keeps the ductus arteriosus open.
Pedea, when given to your baby, can help to close the ductus arteriosus. The active substance in Pedea is ibuprofen. Pedea closes the ductus arteriosus by inhibiting the production of prostaglandin, a naturally occurring chemical in the body which keeps the ductus arteriosus open. 2. What you need to know before pedea is administered to your baby.
PEDEA Solution for injection Usage - MPI, EU: SmPC - RxReasoner
Pedea should be administered as a short infusion over 15 minutes, preferably undiluted. If necessary, the injection volume may be adjusted with either sodium chloride 9 mg/ml (0.9%) solution for injection or glucose 50 mg/ml (5%) solution for injection.
PEDEA Solution for injection Overview - MPI, EU: SmPC
PEDEA Solution for injection Ref.[110129] Active ingredients: Ibuprofen. Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Recordati Rare Diseases, Immeuble Le Wilson, 70, avenue du Général de Gaulle, F-92800 Puteaux, France
- Some results have been removed